Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy
Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients
Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost.
Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Qinghai
-
Xining, Qinghai, Kina, 810000
- Department of gastroenterology, Qinghai Provincial People's Hospital
-
-
Shaanxi
-
Xi'an, Shaanxi, Kina, 710032
- Department of gastroenterology, Shaanxi Second People's Hospital
-
-
Shanxi
-
Xi'an, Shanxi, Kina, 710032
- Endoscopic center, Xijing Hospital of Digestive Diseases
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients undergoing colonoscopy;
Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):
- Constipation
- Diabetes
- Parkinson's disease
- History of stroke or spine cord injure
- Prior history of inadequate bowel preparation
- BMI>25
- Use of tricyclic antidepressant or narcotics
Exclusion Criteria:
- History of colorectal resection;
- Suspected colonic stricture or perforation;
- Incomplete or complete bowel obstruction;
- Use of prokinetic agents or purgatives within 7 days;
- Toxic colitis or megacolon;
- Pregnancy or lactation;
- Unable to give informed consent;
- Haemodynamically unstable.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Single dose of 2L PEG
2 L of PEG solution was used on the day of colonoscopy.
|
Patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy.
Patients began to drink 2 L of PEG 4-6 hours before colonoscopy at a rate of 250 mL every 15 minutes.
|
|
Aktiv komparator: Split-dose of 4L PEG
Split-dose of 4l PEG was used before and on the day of colonoscopy
|
All patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy.
the participants began to drink the first 2 L of PEG at 7:00-9:00 PM on the day before colonoscopy at a rate of 250 mL every 15 minutes.
On the day of the procedure, patients took the remaining 2 L 4-6 hours before colonoscopy.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)
Tidsramme: 1 year
|
The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side.
They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios.
The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.
|
1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Tilbagetrækningstid
Tidsramme: 1 år
|
1 år
|
|
|
Polyp detection rate
Tidsramme: 1 year
|
1 year
|
|
|
Rate of adverse events
Tidsramme: 1 year
|
adverse events, such as vomiting, nausea, headache, abdominal pain
|
1 year
|
|
Cecal intubation rate
Tidsramme: 1 year
|
1 year
|
|
|
Cecal intubation time
Tidsramme: 1 year
|
1 year
|
|
|
Willingness to repeat bowel preparation
Tidsramme: 1 year
|
The number of patients have a willingness to undergo a repeated bowel preparation if needed
|
1 year
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- KY20162097-5
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .